Disposable Syringes Market, By Product Type (Safety Syringes (Automatic Retractable, Manual Retractable, Non-retractable), and Conventional Syringes (Syringes without Needle, Syringes with Needle)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2023

Code : CMI3778

Pages :135

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Disposable Syringes Market: Key Developments

On January 24 2023, Stevanato Group, a global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced its latest collaboration with Transcoject GmbH, a medical device and pharma packaging Solutions Company. The collaboration will enable Stevanato Group to add cyclic olefin polymer (COP) and cyclic olefin copolymer (COC) PFS to its existing portfolio of solutions providing added value in the customers’ supply chain. By integrating Transcoject's technological know-how with Stevanato Group’s capabilities and expertise–in drug containment solutions, manufacturing and market trends-Stevanato Group will be able to offer pre-fillable syringes in glass and in both COP and COC polymers.

In May 2022, Owen Mumford, a global company specialized in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech and generics industries, has signed an exclusive agreement with Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions for the Aidaptus auto-injector. The agreement makes Stevanato Group an exclusive manufacturing partner for the Owen Mumford designed auto-injector, offering a full set of capabilities to its pharmaceutical customers.

On March 16 2023, Stevanato Group S.p.A., a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced a collaboration with Recipharm AB, a Contract Development and Manufacturing Organization (CDMO). Under the agreement, Stevanato Group will lend its manufacturing experience to support the development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers. As part of this collaboration, Stevanato Group will provide and manufacture its glass pre-fillable syringe Alba assembled with the Integrated Spray Module (ISMTM) of Recipharm’s soft mist inhaler technology, the Pre-Filled Syringe Inhaler (PFSITM).

On April 13 2023, Delta Med Group, a manufacturer of medical devices and DBM, a manufacturer of pre-filled syringes announced a strategic partnership to strengthen their positioning in the pre-filled syringes market. Delta Med Group and DBM will expand their portfolio profiting from highly complementary products and R&D capabilities, improving their ability to serve customers. The partnership will generate significant synergies and boost the growth trajectory of the combined entity.